Test to Detect CCP Virus Flawed, Scientists Say

Share this:

Since the beginning of this CCP virus that’s absolutely caused chaos and shutdowns worldwide, the debate about the PCR [polymerase chain reaction] tests has been ongoing. Lots of medical professionals as well as scientist have stated that the test is not an accurate way to determine if someone is infected with the coronavirus.

Just like front line doctors have said, and proven, there are several ways to treat the virus and can be minimized and completely stopped if treated early.

Anyway, I ran across yet another article from The Epoch Times where yet another study has been done to say that the PCR tests are unreliable and inaccurate.


Article Source: Test to Detect CCP Virus Flawed, Scientists Say

 

Fragments of dead virus can thwart the diagnostic tool churning out the numbers that dominate headlines.

Never in medical history has a diagnostic tool been given so much authority as the PCR test, which has been used to detect if someone is infected with the CCP virus.

Many policymakers rely solely on rising positive cases derived from the PCR [polymerase chain reaction] test, and not on deaths or hospitalization rates, to implement restrictive measures that seek to stop the transmission of the CCP (Chinese Communist Party) virus, which causes the disease COVID-19.

But that “gold standard” test is being called into question as an international team of scientists calls for the retraction of a study that details the first PCR test protocol to detect the CCP virus, claiming there were serious technical and scientific errors.

The study, referred to as the Corman-Drosten paper (pdf), “aimed to develop and deploy robust diagnostic methodology for use in public health laboratory settings without having a virus material available.”

Summary of Errors

Borger and his team listed 10 significant problems in the Corman-Drosten paper, suggesting that the authors had failed to validate whether their PCR test could actually detect the CCP virus.

Below is a summary of four of those errors:

1. The PCR test isn’t able to distinguish between an inactive (noninfectious) viral fragment and a whole intact (infectious) virus, making it ineffective as a diagnostic tool for the CCP virus.

2. The cycle threshold value wasn’t mentioned in the study. The threshold is determined by the number of cycles it takes for a PCR test machine to detect the genetic material of the CCP virus. The lower the number, the more the virus (infectious), but the higher the number, the greater the chance of a false-positive.

Many PCR test manufacturers use a cycle threshold cutoff value of 40 cycles, a value that many medical experts believe returns false positives, as fragments of a dead virus may be picked up, according to the Foundation for Innovative New Diagnostics (pdf).

3. The paper doesn’t state the conflicts of interest for several of the authors. Two of them, Drosten and Chantal Reusken, are also associate editors at Eurosurveillance, while Drosten and Victor Corman are affiliated with a commercial test laboratory, where they are “responsible for virus diagnostics.”

Six months after its publication, an author’s correction was finally submitted on July 30, 2020, for Marco Kaiser, who is a “senior researcher at GenExpress and serves as scientific advisor for TIB-Molbiol,” a company to first “produce PCR kits (Light Mix) based on the protocol published in the Corman-Drosten.”

4. “The PCR test contains neither a unique positive control to evaluate its specificity for SARS-CoV-2 nor a negative control to exclude the presence of other coronaviruses, making the test unsuitable as a specific diagnostic tool to identify the SARS-CoV-2 virus,” Borger’s team stated.

 


Share this:
Scroll to Top